Question arises on the existence of ex post facto drug management system

Pharmaceutical business sources say that in parallel with the impending implementation of a new drug price re-evaluation system, the Korea Pharmaceutical Manufacturers Association (KPMA) will call for the government to abolish the current ex post facto drug management that appears to be no longer necessary.

The KPMA also plans to make some proposals to the government, such as amelioration of...